News
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $6.5 Price Target
15 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
What's Going On With MannKind Stock?
11 Mar 24
News, Movers
MannKind Announced Initial Meal Challenge Data From INHALE-3 Phase 4 U.S. Trial Comparing Afrezza Head-to-head With Multiple Daily Injections And Insulin Pumps
11 Mar 24
Biotech, News, Health Care, General
Cramer Says Sprout Social Is In A 'Hot Spot,' But This Energy Stock Is 'Too Down And Out'
8 Mar 24
Long Ideas, News, Small Cap, Top Stories, Markets, Media, Trading Ideas
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $6.5 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
MannKind Q4 2023 Adj EPS $0.02 Beats undefined Estimate, Sales $58.47M Beat $53.58M Estimate
27 Feb 24
Earnings, Earnings Beats, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
MannKind Earnings Preview
26 Feb 24
Earnings
HC Wainwright & Co. Reiterates Buy on MannKind, Maintains $7.5 Price Target
4 Jan 24
News, Price Target, Reiteration, Analyst Ratings
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
2 Jan 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Press releases
MannKind Announces CFO Transition
26 Mar 24
Biotech, News, Management, Press Releases, General
INHALE-3 Study's Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
11 Mar 24
Health Care, Press Releases
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
5 Mar 24
News, Press Releases
MannKind Corporation Announces Participation at Upcoming Conferences
4 Mar 24
News, Press Releases
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
27 Feb 24
Earnings, Press Releases
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
15 Feb 24
Health Care, Press Releases
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
2 Jan 24
News, Financing, Press Releases